It was identified that epacadostat potently activates AhR-mediated signaling, inducing the nuclear translocation of AhR and the upregulation of IDO1 expression (34) in both tumor cells and splenic T cells, leading to immunosuppression (35). This evidence concerns the gene IDO1 and neoplasm.